Event: BTOG 2024

0:00:42

The critical importance of recognizing central airway obstruction in patients

0:01:47

Assessing follow-up strategies in post-surgical lung cancer: insights from a Phase III trial

0:01:05

Management of malignant central airway obstruction

0:01:40

Referring central airway obstruction patients: specialist intervention benefits

0:00:40

National Lung Cancer Audit: state of the nation

0:01:00

Exploring ILD drugs in lung cancer: research gaps and opportunities

0:01:09

Overcoming disparities in cancer care: clinician advocacy and patient empowerment

0:02:26

Targeting KRAS mutations in lung cancer

0:00:42

Promising role of liquid biopsies in lung cancer

0:02:03

Biomarker detection for early cancer detection

0:07:37

What is the optimal follow-up for lung cancer long term survivors?

0:04:06

Evolving definitions of resectability in stage III lung cancer

0:01:21

BTOG 2020: what to expect

0:00:14

From A Fortnite Noob To The Most DANGEROUS Pro 😈

0:03:35

Lung cancer initiation: towards molecular cancer prevention

0:03:42

The evolution of lung cancer treatment toward personalization

0:01:07

Challenges faced in the management of brain metastases and large cell neuroendocrine lung cancers

0:02:24

Challenges in timely assessment and access to care for lung cancer

0:02:45

Assessing operability in NSCLC: challenges and considerations

0:01:43

Immuno-oncology focus: questions to be answered

0:01:36

RadioX: radiographer immediate reporting of chest X-rays

0:02:55

UK needs to improve interface of primary/secondary care for cancer

0:03:00

Educational intervention for carers of lung cancer patients: learning about breathlessness

1:38:09

MET Science